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Variants Associated with Common Disease Are Not Unusually
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Genetic variants that contribute to risk of common disease may differ in frequency across populations more than
random variants in the genome do, perhaps because they have been exposed to population-speciﬁc natural selection.
To assess this hypothesis empirically, we analyzed data from two groups of single-nucleotide polymorphisms (SNPs)
that have shown reproducible ( ) or reported ( ) associations with common diseases. We compared thenp 9 np 39
frequency differentiation (between Europeans and Africans) of the disease-associated SNPs with that of random
SNPs in the genome. These common-disease–associated SNPs are not signiﬁcantly more differentiated across pop-
ulations than random SNPs. Thus, for the data examined here, ethnicity will not be a good predictor of genotype
at many common-disease–associated SNPs, just as it is rarely a good predictor of genotype at random SNPs in the
genome.
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An open question in medical and population genetics is
howmuch information a person’s self-identiﬁed ancestry
(ethnicity) conveys about his or her risk of common
disease (Risch et al. 2002; Burchard et al. 2003; Cooper
et al. 2003). One way in which ethnicity could be in-
formative about common-disease risk is if risk alleles
vary in frequency among populations, which would al-
low ethnicity to be a predictor of whether a person has
a risk allele. This correlation between ethnicity and ge-
notype would be strongest if the disease-associated var-
iants were differentiated in frequency. Although it is
known that random variants in the genome are not par-
ticularly differentiated across populations on average
(Lewontin 1972; Bowcock et al. 1991; Rosenberg et al.
2002), it has been hypothesized that, because of popu-
lation-speciﬁc natural selection, functional SNPs asso-
ciated with common disease may be more differentiated
(Akey et al. 2002; Bamshad et al. 2004). There has been
no empirical attempt to address this question, largely
because so few disease-associated SNPs have been iden-
tiﬁed to date.
We set out to test the hypothesis that common-disease–
associated SNPs are more differentiated than random
SNPs by conducting an empirical evaluation of popu-
lation differentiation in 48 SNPs associated with com-
mon disease. We wanted to study SNPs that were as-
sociated with common, complex traits, so we explicitly
excluded variants associated with Mendelian diseases.
The SNPs were all identiﬁed in a way that would not
create a bias toward unusually high or low levels of
frequency differentiation across populations, since each
of them was initially identiﬁed in studies of single
populations.
We ﬁrst studied nine SNPs reproducibly associated
with common disease (table 1). These SNPs satisﬁed two
criteria: (1) 175% of replication studies showed a sta-
tistically signiﬁcant association (Hirschhorn et al. 2002)
or the association was signiﬁcant after meta-analysis of
replication studies (Lohmueller et al. 2003) and (2) al-
lele-frequency information was publicly available for
the SNPs in both West African and European-derived
populations.
Second, we studied 39 SNPs that have been reported
to be associated with common disease (table 2) but for
which association has not necessarily been replicated.
These were identiﬁed by checking the genes sequenced
by the Seattle SNPs project (Seattle SNPs Web site) for
overlap with the SNPs reported to be associated with
common disease in the OMIM and PubMed databases
or in table 1 of Hirschhorn et al. (2002).
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Table 1







CTLA4 T1DM Thr17Ala Ala .38 (1,670) .209 (402) .171 .06 Osei-Hyiaman et al. 2001; Lohmueller et al. 2003
DRD3 Schizophrenia Ser9Gly Ser/Ser .67 (202) .116 (112) .554 .458 Crocq et al. 1996; Lohmueller et al. 2003
AGT Hypertension Thr235Met Thr .42 (3,034) .91 (658) .49 .358 Rotimi et al. 1996; Nakajima et al. 2002
PRNP CJD Met129Val Met .72 (138) .556 (72) .164 .049 Hirschhorn et al. 2002; Soldevila et al. 2003
F5 DVT Arg506Gln Gln .044 (1,236) .00 (251) .044 .03 Rees et al. 1995; Hirschhorn et al. 2002
HFE HFE Cys382Tyr Tyr .038 (2,900) .00 (806) .038 .024 Feder et al. 1996; Merryweather-Clarke et al. 1997
MTHFR DVT C677T T .3 (188) .066 (468) .234 .205 Schneider et al. 1998; Ray et al. 2002
PPARG T2DM Pro12Ala Pro .925 (120) 1.0 (120) .075 .067 Altshuler et al. 2000; HapMap Project
KCNJ11 T2DM Asp23Lys Lys .36 (96) .09 (98) .27 .182 Florez et al. 2004
a CJD p Creutzfeldt-Jacob disease; DVT p deep venous thrombosis; HFE p hemochromatosis; T1DM p type I diabetes; T2DM p type
II diabetes.
b The associated allele is the SNP associated with disease, regardless of whether it is the derived or the ancestral allele. The frequencies for
this allele are given.
c The reference that claims this to be a reproducible association, as well as the reference from which the allele frequencies were taken. For
allele frequencies obtained from a meta-analysis, only the reference claiming reproducible association is given.
d Allele frequency obtained from the literature involving a European population. Either the general population frequency or the frequency
in control groups in an association study was used. To reduce bias, when a control frequency was used for Europeans, a control frequency was
also used for Africans. The total number of chromosomes surveyed is given in parentheses after each frequency.
e Allele frequency obtained from the literature involving a West African population. The total number of chromosomes surveyed is given in
parentheses after each frequency.
f d p The difference in the allele frequency between Europeans and Africans.
To assess whether the disease-associated SNPs are
more differentiated across populations than random
SNPs in the genome, we compared the two groups of
disease-associated SNPs with SNPs from two public da-
tabases (table 3). The ﬁrst database (“WICGR”) was
generated by the Whitehead/MIT Center for Genome
Research and includes frequency data for SNPs geno-
typed in European American and Nigerian populations
(see The SNP Consortium Allele Frequency/Genotype
Project Web site). Since this data set includes a West
African population, it was compared to the reproduc-
ible-disease-association group. The second database
(“Perlegen”) consists of SNPs for which frequency in-
formation is available in both European and African
American populations (Hinds et al. 2005); it also has
the virtue of including genotypes of the same samples
that were studied for the Seattle SNPs project. For both
databases, the physical map position, gene name, and
SNP type were downloaded from dbSNP by a batch
query of “rs” numbers (National Center for Biotech-
nology Information, dbSNP build 120, March 2004).
SNPs were excluded from analysis if they were (a) not
polymorphic, (b) mapped to more than one chromo-
somal location, or (c) within 20 kb of each other. The
ﬁnal WICGR data set consisted of 2,377 SNPs, and the
ﬁnal Perlegen data set consisted of 103,536 SNPs. To
measure differentiation between European- and African-
derived populations for the SNPs in all four data sets,
we calculated FST (Weir and Cockerham 1984; Weir
1996), a classic measure of the frequency differentiation
of a polymorphism.
To determine whether the average FST of 0.159 in the
group of nine SNPs that were reproducibly associated
with common disease was signiﬁcantly larger than the
average for random SNPs in the WICGR data set, we
subsampled theWICGR data 10,000 times, counting the
proportion of times that nine SNPs randomly chosen
from WICGR had an average . We did notF  0.159ST
ﬁnd a signiﬁcant increase in average FST in the repro-
ducible-association set relative to the random group
( ). The same subsampling method also did notPp .12
detect an excess in the percentage of SNPs with F 1ST
( ). To obtain an upper bound on the level0.3 Pp .26
of differentiation at common-disease–associated SNPs,
we performed bootstrap resamplings of the data from
the nine reproducibly associated SNPs. Of 10,000 boot-
strap replicates, 95% had average FST values in the range
0.074–0.274, which, as expected, is consistent with the
average FST of the random SNPs.
A potential concern with this analysis is that different
numbers of samples were used to calculate FST for the
disease-associated and WICGR data sets. We therefore
repeated our analysis after randomly dropping samples
from the WICGR data set and the reproducible-disease-
association data set until only 72 African and 72 Eu-
ropean alleles for each SNP remained. More speciﬁcally,
for the reproducible-disease-association group, we per-
formed the random sample-dropping procedure for the
Table 2







ADRB1 MI Arg389Gly Arg .717 (46) .467 (30) .251 .1 Iwai et al. 2003
ALOX5AP MI, stroke rs10507391 T .682 (44) .159 (44) .523 .425 Helgadottir et al. 2004
CAT Hypertension 844 (C/T) Tg .714 (42) .659 (44) .055 0 Jiang et al. 2001
CCR2 AIDS susceptibility Ile64Val Val .87 (46) .813 (48) .057 0 Smith et al. 1997
CD36 Malaria Y to stop Stop 0 (46) .083 (48) .083 .062 Aitman et al. 2000
F13 MI Val34Leu Val .762 (42) .795 (44) .033 0 Kohler et al. 1999
FGA Pulmonary embolism Thr312Ala Ala .2 (40) .5 (42) .3 .159 Carter et al. 2000
GP1BA CAD Thr145Met Met .022 (46) .167 (48) .145 .095 Gonzalez-Conejero et al. 1998
ICAM1 MS Lys469Glu Lys .643 (42) .875 (48) .232 .12 Nejentsev et al. 2003
ICAM1 Malaria Lys29Met Met 0 (46) .354 (48) .354 .335 Fernandez-Reyes et al. 1997
IFNGR1 Hp infection 56 (C/T) T .455 (44) .604 (48) .15 .023 Thye et al. 2003
IL13 Asthma 1055 (C/T) T .196 (46) .25 (44) .054 0 van der Pouw Kraan et al. 1999
IL13 Bronchial asthma Arg110Gln Gln .273 (44) .119 (42) .154 .05 Heinzmann et al. 2003
IL1A AD 889 (C/T) T .295 (44) .391 (46) .096 0 Nicoll et al. 2000
IL1B Gastric cancer 31 (C/T) T .826 (46) .375 (48) .451 .335 El-Omar et al. 2000
IL3 RA 16 (C/T) C .739 (46) .875 (48) .136 .037 Yamada et al. 2001
IL4 Asthma 590 (T/C) T .174 (46) .708 (48) .534 .436 Noguchi et al. 1998
IL4R Asthma Gln576Arg Arg .295 (44) .565 (46) .27 .118 Hershey et al. 1997
IL6 Juvenile arthritis 174 (C/G) G .5 (44) 1 (46) .5 .494 Fishman et al. 1998
IL8 RSV bronchiolitis 251 (T/A) Th .659 (44) .229 (48) .43 .301 Hull et al. 2000
ITGA2 MI 807 (C/T) T .316 (38) .25 (48) .066 0 Moshfegh et al. 1999
LTA MI Thr26Asn Asn .357 (42) .5 (44) .143 .018 Ozaki et al. 2002
MC1R Fair skin Val92Met Met .068 (44) 0 (44) .068 .047 Valverde et al. 1995
NOS3 MI Glu298Asp Asp .5 (44) .136 (44) .364 .247 Shimasaki et al. 1998
PLAU AD Pro141Leu Pro .659 (44) .979 (48) .32 .287 Finckh et al. 2003
PON1 CAD Arg192Gln Arg .174 (46) .727 (44) .553 .461 Serrato and Marian 1995
PON2 CAD Cys311Ser Ser .826 (46) .762 (42) .064 0 Sanghera et al. 1998
PTGS2 Colon cancer 765 (G/C) C .238 (42) .292 (48) .054 0 Koh et al. 2004
PTPN22i RA Arg620Trp Trp .084 (1,120) .024 (818) .059 .03 Begovich et al. 2004
SELE CAD Ser128Arg Arg .091 (44) .021 (48) .07 .025 Wenzel et al. 1994
SELL IgA nephropathy Pro238Ser Ser .065 (46) .333 (48) .268 .183 Takei et al. 2002
SELP MI Thr715Pro Thr .864 (44) .977 (44) .114 .063 Herrmann et al. 1998
SFTPB ARDS Ile131Thr Thr .5 (44) .348 (46) .152 .025 Lin et al. 2000
SPD RSV infection Met11Thr Met .568 (44) .478 (46) .09 0 Lahti et al. 2002
TF AD Pro570Ser Pro .957 (46) .935 (46) .022 0 Zhang et al. 2003
THBD MI Ala455Val Ala .87 (46) .848 (46) .022 0 Norlund et al. 1997
THBS4 MI Ala387Pro Pro .341 (44) .083 (48) .258 .166 Topol et al. 2001
TNFA Infectious disease 308 (A/G) A .182 (44) .205 (44) .023 0 Bayley et al. 2004
VCAM1 Stroke in SCD Gly413Ala Gly 1 (46) .938 (48) .063 .041 Taylor et al. 2002
a AD p Alzheimer disease; AIDS p acquired immunodeﬁciency syndrome; ARDSp acute respiratory distress syndrome; CADp coronary
artery disease; Hpp Helicobacter pylori; MIp myocardial infarction; MSp multiple sclerosis; RAp rheumatoid arthritis; RSVp respiratory
syncytial virus; SCD p sickle cell disease.
b The associated allele is the SNP associated with disease, regardless of whether it is the derived or the ancestral allele. The frequencies for
this allele are given.
c The reference that reported association with the listed disease/phenotype.
d Frequency obtained from the Seattle SNPs database for the European sample. The total number of chromosomes surveyed is given in
parentheses after each frequency.
e Frequency obtained from the Seattle SNPs database for the African American sample. The total number of chromosomes surveyed is given
in parentheses after each frequency.
f d p The difference in the allele frequency between African Americans and Europeans.
g Associated allele in database is A.
h Associated allele in reference is A.
i This SNP was not from the Seattle SNPs database; instead, allele frequencies from Begovich et al. (2004) were used.
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Table 3
Summary of FST Values for Comparison of Disease-Association and Genomewide Data Sets
Data Set Populations Studied No. of SNPs Average FST
a No. (%) with F 1 .3ST
WICGR:
All SNPs European and Nigerian 2,377 .119 237 (9.97)
72 allelesb European and Nigerian 2,348 .113 233 (9.92)
Perlegen:
All SNPs European and African American 1,465,325 .083 88,138 (6.01)
20 kb apartc European and African American 103,536 .085 6,717 (6.49)
Reproducible associations European and West African 9 .159 (.074–.274)d 2 (22.22)
Reported associations European and African American 39 .120 (.077–.171)d 7 (17.95)
a Average FST values for African-derived and European-derived populations.
b WICGR data set after the sample size was decreased to 72 chromosomes at each SNP for both populations (see main
text).
c Only SNPs that are at least 20 kb apart were used; this should decrease correlations among SNPs that are due to linkage
disequilibrium.
d Average FST and, in parentheses, 95% CIs obtained by bootstrapping.
nine SNPs 1,000 times and recalculated FST for each
replicate. The average FST and the percentage of FST val-
ues 10.3 in both data sets were extremely similar and
were nearly identical to those observed in our original
data sets, and we again could not reject the null hy-
pothesis of no difference between the disease-associated
and random SNPs (table 3).
We followed an identical protocol to compare FST in
the group of SNPs with reported disease association to
FST of SNPs in the Perlegen database. Here, there was
no problem of sample size or sample mismatch, since
the Perlegen set was genotyped in the same European
American and African American individuals who were
assayed for the disease-associated SNPs by the Seattle
SNPs project. We did not ﬁnd a signiﬁcant increase in
average FST ( ) or in the percentage of SNPs withPp .13
( ) in the reported-disease-associationF 1 0.3 Pp .29ST
group relative to the Perlegen data set. To obtain a 95%
CI for the differentiation, we performed 10,000 boot-
strap resamplings of the 39 SNPs. The 95% CI is 0.074–
0.171 and includes the genomewide average FST of the
Perlegen data set (0.083) (table 3), which explains why
the null hypothesis of no excess differentiation in the
disease-associated SNPs relative to the random SNPs
cannot be rejected. Because more SNPs are available for
the reported-association group than for the reproduci-
ble-association group, we were able to put a more strin-
gent upper bound on FST for the reported-association
group.
Another question in medical genetics is whether dis-
ease-associated SNPs in the genome are more differen-
tiated than random nonsynonymous SNPs (Freedman et
al. 2004). To test this, we performed an analysis of the
reported-association group in comparison with 6,763
nonsynonymous SNPs from the Perlegen data set (which
may, of course, include some disease-associated SNPs).
We did not ﬁnd a signiﬁcant increase in average FST
( ) or in the percentage of SNPs withPp .06 F 1 0.3ST
( ) in the reported-disease-association group rel-Pp .13
ative to the nonsynonymous SNPs from the Perlegen
data set.
The SNPs associated with common disease that we
investigated do not show much higher levels of differ-
entiation than those of random SNPs. Thus, in these
cases, ethnicity is a poor predictor of an individual’s
genotype, which is also the pattern for random variants
in the genome. This lends support to the hypothesis that
many population differences in disease risk are environ-
mental, rather than genetic, in origin. However, some
exceptional SNPs associated with common disease are
highly differentiated in frequency across populations, be-
cause of either a history of random drift or natural se-
lection. The exceptional SNPs given in tables 1 and 2
are located in AGT, DRD3, ALOX5AP, ICAM1, IL1B,
IL4, IL6, IL8, and PON1.Of note, evidence of selection
has been observed for AGT (Nakajima et al. 2004), IL4
(Rockman et al. 2003), IL8 (Hull et al. 2001), and
PON1 (Allebrandt et al. 2002). Yet, for the vast majority
of the common-disease–associated polymorphisms we
examined, ethnicity is likely to be a poor predictor of
an individual’s genotype.
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